*News On Societal CDMO Inc. (SCTL) Now Under CRX.XX
Dow Jones · 04/08 21:08
*Societal CDMO: Common Stk of Societal CDMO Will Be Delisted From Nasdaq >SCTL
Dow Jones · 04/08 20:07
SOCIETAL CDMO INC: Current report
Press release · 04/08 16:01
Societal CDMO Completes Merger and Resolves Financial Obligations
TipRanks · 04/08 15:22
Press Release: CoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.
CoreRx, Inc. Completes Acquisition of Societal CDMO, Inc., a contract development and manufacturing organization focused on small molecule therapeutics. The tender offer to acquire all of the issued and outstanding shares of common stock of societalCDMO expired on April 5, 2024. CoreRx completed the acquisition through a planned second-step merger.
Dow Jones · 04/08 14:10
*CoreRx, Inc. Completes Acquisition Of Societal CDMO, Inc. SCTL
Dow Jones · 04/08 14:10
Weekly Report: what happened at SCTL last week (0401-0405)?
Weekly Report · 04/08 09:57
Weekly Report: what happened at SCTL last week (0325-0329)?
Weekly Report · 04/01 09:57
Why Is Joann (JOAN) Stock Down 11% Today?
Joann (NASDAQ:JOAN) stock is falling on Monday as investors wait for the craft supplies company’s shares to be delisted following its recent bankruptcy filing. JOAN stock is down 10.6% as of Monday morning. The company will no longer be listed on the Nasdaq when markets open on Thursday. We have all of the stock market news you need to know about on Monday. Sintx Technologies stock, Societal CDMO stock and MicroAlgo stock are all down today.
Investorplace · 03/25 13:25
Why Is Sintx Technologies (SINT) Stock Down 31% Today?
Sintx Technologies (NASDAQ:SINT) stock is down 30.6% as of Monday morning. The medical device company announced its plans for a proposed public offering of SINT shares on Friday. The company has yet to announce the pricing of the SINT stock offering. SINT is down 76.3% year-to-date.
Investorplace · 03/25 13:05
SCTL Stock Earnings: Societal CDMO Beats Revenue for Q4 2023
Societal CDMO (NASDAQ:SCTL) just reported results for the fourth quarter of 2023. The company did not report any EPS for the quarter. Societal CD MO reported revenue of $27.72 million. This was 8.79% better than the analyst estimate for revenue.
Investorplace · 03/25 12:52
Weekly Report: what happened at SCTL last week (0318-0322)?
Weekly Report · 03/25 09:58
Societal Cdmo at the Crossroads: Merger with CoreRx Faces Uncertain Future and Financial Risks
Societal Cdmo faces significant uncertainty with the completion of its merger with CoreRx. Multiple conditions pose risks to the timely finalization of the transaction. The average SCTL stock price target is $1.10, implying 0.92% upside potential.
TipRanks · 03/24 06:01
SOCIETAL CDMO INC: Annual report
Press release · 03/23 00:03
Societal CDMO Inc reports results for the quarter ended in December - Earnings Summary
Societal CDMO Inc reports results for the quarter ended in December. Revenue rose 14.2% to $27.72 million from a year ago. The company reported a quarterly adjusted loss of 1 cent per share. Societal CD MO Inc shares had risen by 202.4% this quarter.
Reuters · 03/22 23:56
Weekly Report: what happened at SCTL last week (0311-0315)?
Weekly Report · 03/18 09:57
SOCIETAL CDMO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Societal CDMO, Inc. - SCTL
Former Attorney General of Louisiana Charles C. Foti, Jr. And the law firm of Kahn Swick & Foti are investigating the proposed sale of Societal CDMO, Inc. To CoreRx. Under the terms of the proposed transaction, shareholders will receive $1.10 in cash for each share. KSF is seeking to determine whether the consideration undervalues the Company.
Barchart · 03/13 10:39
Weekly Report: what happened at SCTL last week (0304-0308)?
Weekly Report · 03/11 09:56
SOCIETAL CDMO INC: General statement of acquisition of beneficial ownership
Press release · 03/07 10:01
SOCIETAL CDMO INC: Statement of changes in beneficial ownership of securities
Press release · 03/04 22:01
Webull provides a variety of real-time SCTL stock news. You can receive the latest news about SOCIETAL CDMO INC through multiple platforms. This information may help you make smarter investment decisions.
About SCTL
Societal CDMO, Inc. is a bi-coastal contract development and manufacturing organization (CDMO). The Company is engaged in spanning pre-investigational new drug development to commercial manufacturing and packaging for a range of therapeutic dosage forms with a primary focus in the area of small molecules. It is a CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market. The Company's key products include Ritalin LA, Focalin XR, Verelan PM, Verelan SR, Verapamil PM, Verapamil SR and Donnatal liquids and tablets. Its manufacturing and development capabilities include product development from formulation through clinical trial and commercial manufacturing, and specialized capabilities for solid oral dosage forms, with specialization in modified release technologies and facilities to handle potent compounds and controlled substances.